Vertex to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10

Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 9:00 a.m. ET. A live webcast of the presentation will be available on Vertex's website, with a replay archived afterward.

Vertex is a global biotechnology company focused on transformative medicines for serious diseases, particularly cystic fibrosis (CF). The company's pipeline includes investigational therapies for diseases like sickle cell disease and type 1 diabetes. Vertex has received numerous accolades as a top employer in the industry.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the 40^th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 9:00 a.m. ET.

A live webcast of management's remarks will be available through Vertex's website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. In addition, Vertex has a rapidly expanding pipeline of cell and genetic therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list, one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies, and a best place to work for LGBTQ equality by the Human Rights Campaign. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005909/en/

Vertex Pharmaceuticals Incorporated Investors:

Michael Partridge, 617-341-6108

Manisha Pai, 617-429-6891

Miroslava Minkova, 617-341-6135

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Vertex Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Vertex Pharmaceuticals will present on January 10, 2022, at 9:00 a.m. ET.

How can I listen to Vertex Pharmaceuticals' presentation at the conference?

The presentation can be accessed via a live webcast on the Vertex website in the 'Investors' section.

What is Vertex Pharmaceuticals' focus in terms of medicinal development?

Vertex focuses on creating transformative therapies for serious diseases, particularly cystic fibrosis and other diseases like sickle cell disease.

Where is Vertex Pharmaceuticals headquartered?

Vertex Pharmaceuticals is headquartered in Boston, Massachusetts.

What accolades has Vertex Pharmaceuticals received?

Vertex has been recognized as one of the top places to work, including 12 consecutive years on Science magazine's Top Employers list.